• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Clinical Trial Registry Accuracy and Maintenance in ALS/MND Research
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition, Swallowing and Saliva
      • Activities of Daily Living and Occupational Therapy
      • Muscles, Mobility and Exercise
      • Respiratory Care
      • Speech and Communication
      • Voice Preservation
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
    • R.A.C.E. to Diagnose ALS/MND
  • Programs & Events
    • Calendar of Events
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
  • Members
    • Member Registration
    • Forgot Password

International Alliance

  • Profile
  • Topics Started
  • Replies Created
  • Engagements
  • Favorites

Favorite Forum Topics

  • Oh, bother! No topics were found here.

Primary Sidebar

Advocacy

  • Advocacy Toolkit

Approved Drugs

  • Nuedexta
  • Radicava/Edaravone
  • Riluzole/Tiglutik
  • Rozebalamin / Methylcobalamin
  • Tofersen/Qalsody

Drugs in Development

  • AB Science – Masitinib
  • NurOwn
  • Clene Nanomedicine – CNM-Au8
  • ILB
  • Kadimastem – AstroRx
  • Neuronata-R / Lenzumestrocel
  • NeuroSense – PrimeC
  • NP001
  • Prilenia Therapeutics – Pridopidine
  • SOD1 Therapies & Trials
  • SPG302
  • Regulatory T Cell Enhancing Therapies
  • Ulefnersen

Care services

  • Genetic Counselling & Testing
  • Mental Health Support
  • Nursing and Symptom Management
  • Nutrition, Swallowing and Saliva
  • Activities of Daily Living and Occupational Therapy
  • Muscles, Mobility and Exercise
  • Respiratory Care
  • Speech and Communication
  • Support for Family & Caregivers
  • Technology

Support for members

  • Alliance Support Grant
  • About the meetings

Programs & Events

  • Calendar of Events/Programs
  • Alliance Webinars
  • Alliance Meeting
  • Allied Professionals Forum
  • ALS/MND Connect
  • Global Day Calendar
  • March of Faces
  • International Symposium

About

  • Who We Are
  • Board of Trustees
  • Councils, Forums & Committees
    • PALS and CALS Advisory Council
    • Scientific Advisory Council
    • Advocacy and Public Policy Forum
    • Research Directors Forum
    • Governance Committee
    • Finance Committee
  • Staff
  • History
  • Newsletter Archive
    • Meetings
  • Awards

Upcoming Events

Nov 19
12:00 pm - 1:00 pm CST

Les Turner ALS Foundation Webinar: The Caregiver’s Journey

Nov 20
7:45 am - 5:15 pm MST

Canadian Society of Palliative Medicine: Palliative Horizons – Clinical Approaches to ALS and Parkinson’s

Nov 24
9:00 am - 10:30 am EST

Annual General Meeting

Dec 5
December 5 - December 6

Alliance Meeting

Dec 7
December 7 - December 8

Allied Professionals Forum

View Calendar

  • Glen Elison, USA

    Glen Elison, USA

  • H. Todd Kelly, USA

    H. Todd Kelly, USA

  • Chen Chun-Chin, Malaysia

    Chen Chun-Chin, Malaysia

  • Hiroshi Matsuyama, Japan

    Hiroshi Matsuyama, Japan

  • Joy Blakeley, Australia

    Joy Blakeley, Australia

  • Daniel Hare, USA

    Daniel Hare, USA

  • Jean

    Jean
    jean

  • Charlie Dourney, USA

    Charlie Dourney, USA

  • Anita Forte, USA

    Anita Forte, USA

  • Vincent Bourque, Canada

    Vincent Bourque, Canada
    vincent_bourque

  • Richard Clark, New Zealand

    Richard Clark, New Zealand

  • Nicholas (Nic) Bowman, South Africa

    Nicholas (Nic) Bowman, South Africa

  • Sam Hayden-Harler, UK

    Sam Hayden-Harler, UK

  • Conny van der Meijden, Netherlands

    Conny van der Meijden, Netherlands

  • Phil Rossall, UK

    Phil Rossall, UK

  • Alejandro Aquino, Argentina

    Alejandro Aquino, Argentina

  • Lombana, Spain

    Lombana, Spain

  • Susan Anderson, USA

    Susan Anderson, USA

  • Jon Newsome, USA

    Jon Newsome, USA

  • Liong Ting Ngu, Malaysia

    Liong Ting Ngu, Malaysia

  • Sharon Corosanite, USA

    Sharon Corosanite, USA

  • Alfredo Santos, Colombia

    Alfredo Santos, Colombia

  • Gisli Jonasson, Iceland

    Gisli Jonasson, Iceland

  • Duncan Bayly, Australia

    Duncan Bayly, Australia

  • Ywan Dierick, Belgium

    Ywan Dierick, Belgium

  • Mike Cels, Canada

    Mike Cels, Canada

  • Fabio Carvalho, Brazil

    Fabio Carvalho, Brazil

  • Roy Taylor, Ireland

    Roy Taylor, Ireland
    roy

  • Lee Millard, England

    Lee Millard, England

  • Bob Spurrier, USA

    Bob Spurrier, USA

  • Marcel R. Wernard, Netherlands

    Marcel R. Wernard, Netherlands

  • Den Haag, Netherlands

    Den Haag, Netherlands

  • Purningam Jacob, India

    Purningam Jacob, India

  • Shaleen Latchman, Canada

    Shaleen Latchman, Canada

  • Joyce Rusinak, USA

    Joyce Rusinak, USA

  • Wilfried Leusing, Germany

    Wilfried Leusing, Germany

  • Liam Dwyer, England

    Liam Dwyer, England

  • Dawn Morton, Scotland

    Dawn Morton, Scotland

  • Shay Rishoni, Israel

    Shay Rishoni, Israel

  • Catherine Pearce, Australia

    Catherine Pearce, Australia

  • Andrea Zicchieri, Italy

    Andrea Zicchieri, Italy
    AndreaZicchieri_conSLAncioItaly

  • Eric Von Schaumburg, USA

    Eric Von Schaumburg, USA

  • Elkin Gaviria, Colombia

    Elkin Gaviria, Colombia

  • Ann Nicol, USA

    Ann Nicol, USA

  • Maria Santos Garcia Tellez, Mexico

    Maria Santos Garcia Tellez, Mexico

  • Cath Muir, UK

    Cath Muir, UK
    Cath

  • Jay Epstein, USA

    Jay Epstein, USA

  • Feng Gin Sun, China

    Feng Gin Sun, China

  • Semra Gokalp, Turkey

    Semra Gokalp, Turkey

  • Anna Barrow, UK

    Anna Barrow, UK

Learn more about the March of Faces

Coronavirus (COVID-19) Resources

Instructions

First-time users, please register by clicking the register button below this log in form. You will then be able to create a user name and password. Only Alliance members are eligible to register.

If you have already registered, please use the details provided to log in using this form.

Drugs No Longer in Development

  • AMX0035
  • Reldesemtiv
  • Arimoclomol
  • TUDCA

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login